Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Pathways’ Picks January 12: EU Standards, Stalled Fee Talks, QSR Reform Progress, and More

In this week’s roundup: Watching for a restart to FDA user fee talks and Califf’s confirmation. EU steps on standards, companion diagnostics, health technology assessments, and notified bodies. FDA progresses on quality system harmonization and device shortage notifications, and forges a new imaging office. More from the US, Canada, UK, and Singapore.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Business Strategies

HighLife’s Near-Death Experience

Equity investments from strategics are great for promising start-ups…until they’re not. Transcatheter mitral valve repair company HighLife thought it had found an alternative to traditional venture funding with an investment from a strategic. But several years into the relationship, the strategic had second thoughts, leaving HighLife scrambling to stay in business.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Perspective & Commentary

Market Pathways Top 5: November 2021

The top five Market Pathways articles posted in November to MyStrategist.com, chosen by readers and editors, include leveraging AI/machine learning to improve outcomes, Hawthorne Effects model for decentralized trials, Apple's Afib clearance, and our recurring columns FDA Output and Market Scorecard.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More